Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
LTGO Long-term Debt
Borrowings due after more than one year.
No reported Long-term Debt figures are available to summarize.
Long-term Debt history
Currency unavailable · from the balance sheet
No Long-term Debt data reported for this period type.
Long-term Debt vs competitors
How LTGO compares with its peers on the latest reported figures
LTGO Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $773.98M USD | +0.1% | +18.9% | 46.9% | |
| Mar 2026 | $367.66M USD | -3.6% | -14.6% | 30.4% | |
| Mar 2026 | $5.6M USD | — | — | 1.9% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -1.7% | +2.2% | 30.4% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.